Copyright
©The Author(s) 2016.
World J Nephrol. Jul 6, 2016; 5(4): 308-320
Published online Jul 6, 2016. doi: 10.5527/wjn.v5.i4.308
Published online Jul 6, 2016. doi: 10.5527/wjn.v5.i4.308
Nonspecific treatment |
Replace deficient gene products |
Plasma infusion |
Liver Transplantation |
Eliminate autoantibodies and/or mutant proteins |
Plasma exchange |
Immunosuppression |
Treatment of plasma cell dyscrasia |
Inhibition of complement activation |
Eculizumab (anti C5) |
Inhibition of the C3 Convertase |
Renal transplantation |
New trials ongoing |
- Citation: Salvadori M, Rosso G. Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GN. World J Nephrol 2016; 5(4): 308-320
- URL: https://www.wjgnet.com/2220-6124/full/v5/i4/308.htm
- DOI: https://dx.doi.org/10.5527/wjn.v5.i4.308